YushanUnclaimed
Host of 硅谷101. Guest on 硅谷101.
Host, 硅谷101
4 Feed-stated
Counts Verified and Feed-stated credits: what a show's own feed states, or a confirmation backs. See the record
- Host
- Podcast guest
Claim this profile Add a creditIs this you? Claiming needs a free account. You sign in or join, then come straight back here.
This profile is unclaimed. PodSubs built it from public show feeds and credits. The person it is about has not reviewed it yet.
About
Yushan has been a guest on 2 episodes on 硅谷101, most recently in May 2025. That show covers technology. Yushan also hosts 硅谷101.
Written by PodSubs from Yushan's credits.
PodCred record
PodCred is the verified record of where Yushan has worked and appeared. These credits come from the shows' own feeds and wait for people who were there to confirm them.
Worked with Yushan on a show? This is where you give them credit.
Shows they work on now
1 show
Guest appearances
2 episodes
E193|吃益生菌是智商税吗?全面复盘肠道健康迷思
你知道吗,我们每个人的肠道内都住着数以几十到几百万亿计的“外来者” - - 细菌、病毒、真菌等微生物。它们的基因复杂程度,甚至比人类还高几十倍。它们不但帮我们消化、制造关键营养物质,还可能影响我们的免疫系统,甚至情绪和心理健康。从出生时顺产还是剖腹产、每天吃什么食物、睡眠是否充足,到有没有养宠物,甚至使用抗生素,都会左右你体内这片“微生物宇宙”的生态平衡。...
Feed-statedE190|司美格鲁肽的新对手们:制药巨头混战减肥药下半场
近两年,减肥药成了医药行业里最炙手可热的明星概念。从诺和诺德的司美格鲁肽semaglutide到礼来的替尔泊肽tirzepatide,一系列GLP-1类药物席卷市场,引发了公众与资本市场对代谢类药物前所未有的关注。而除了这两位先行者,更多大药企也在持续加注:一边自研新一代药物管线,一边通过收购切入,比如近日罗氏以最高总金额53亿美金重金买下Zealand管线,押注曾被忽视的amylin通路。减肥药,不再只是一个产品,而是一场全面的产业竞...
Feed-stated
Availability
Availability not set yet.
Is an appearance missing?
People get invited back because someone remembered they were great. If you heard this person on a show and it is not listed here, add it. Your memory might be the reason they get their next invitation.
No account needed. Anyone can give a credit.
Featured
Picked by PodSubs from Yushan's confirmed appearances.
Experience, education, skills, and recommendations start empty. They fill in when Yushan claims this profile.
Recommendations
No recommendations for Yushan yet.
Recommendations open once Yushan claims the profile.

